108
Participants
Start Date
January 17, 2017
Primary Completion Date
November 2, 2024
Study Completion Date
November 2, 2024
Hypofractionated stereotactic radiation therapy
Durvalumab
Institut de Cancerologie de L'Ouest, Angers
Centre Paul Strauss, Strasbourg
Hopital Pitie Salpetriere, Paris
Hopital Avicenne, Bobigny
Centre Francois Baclesse, Caen
Centre Georges Francois Leclerc, Dijon
Institut Regional Du Cancer de Montpellier, Montpellier
Institut Curie, Saint-Cloud
Institut Claudius Regaud, Toulouse
Institut Gustave Roussy, Villejuif
Collaborators (1)
AstraZeneca
INDUSTRY
Institut Claudius Regaud
OTHER